Caprotec Bioanalytics' Series B Round

Caprotec Bioanalytics raised a round of funding on May 09, 2011.

Caprotec Bioanalytics focuses on the commercialization of its proprietary Capture Compound Mass Spectrometry (CCMS) technology in the areas of functional proteomics, drug development and development o…

Articles about Caprotec Bioanalytics' Series B Round: